ADVERTISEMENT
Cytal™ Burn Matrix
Cytal® Burn Matrix is a medical device manufactured using proprietary MatriStem® UBM (Urinary Bladder Matrix) technology. The device maintains an intact epithelial basement membrane and facilitates the body's ability to remodel site-appropriate tissue. Cytal Burn Matrix is appropriate for the management of second-degree burns.
Integra LifeSciences Corp.
Integra LifeSciences Corp.
Integra offers innovative solutions in neurosurgery with a broad portfolio of products and solutions for dural access and repair, cerebral spinal fluid management and neuro-critical care. The regenerative tissue technologies portfolio includes products that address soft tissue, nerve and tendon repairs and are used in the treatment of acute and chronic wounds, burns, as well as plastic and reconstructive surgery.
5cmx5cm to 10cmx15cm.
• Maintains and supports a healing environment through constructive remodeling
• Comprised of naturally-occurring urinary bladder matrix
• Contains basement membrane and numerous collagens
• Maintains an intact epithelial basement membrane
• Non-crosslinked wound management scaffold
• Appropriate for acute and chronic wounds
• Complements standard of care
• Fenestrated sheets
Cytal™ Burn Matrix (meshed sheets) are intended for the management of wounds including: second-degree burns, partial- and full-thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/undermined wounds, surgical wounds (donor sites/grafts, post-Mohs surgery, post-laser surgery, podiatric, wound dehiscence), trauma wounds (abrasions, lacerations, skin tears) and draining wounds. This device is intended for one-time use.
Contraindicated for use on patients with known sensitivity or allergy to porcine materials and third-degree burns.
Cytal™ Burn Matrix is intended for one-time use. Do not re-use or sterilize. Do not use if package seal has been broken. Complications and reactions are possible with any soft tissue repair, including but not limited to: infection, increased chronic inflammation, allergic reaction, unexplained fever or chills, excessive redness, pain or swelling.
Store in a clean, dry environment between 15°C-35°C (59°F-95°F) in unopened and undamaged package.
Clean wound bed by removing necrotic tissue and scar tissue to obtain fresh tissue edges. Irrigate excessive exudates and control bleeding. Remove Cytal™ Burn Matrix from container using standard aseptic methods. Cut device slightly bigger than area of wound to be covered. Rehydrate Cytal™ Burn Matrix in room temperature sterile saline or sterile lactated Ringer's solution in a sterile dish for five minutes prior to use.
Large wound: More than one device may be needed to cover wound area. Overlap Cytal™ Burn Matrix edges slightly to ensure complete coverage.
Wet wound: Cover device with non-adherent dressing such as petrolatum gauze, followed by application of an absorptive dressing such as a calcium alginate. Secure dressings to wound site.
Dry wound: The non-adherent dressing should be followed by application of a hydrogel dressing to keep wound moist. Secure dressings to wound site. Keep device and wound bed moist.